US Stock Futures and Bond Yields Decline on Reports of Putins Updated Nuclear Doctrine HPCL Options Strategy Long Strangle Anticipates ShortTerm Volatility Gains Spotify Surges 13 on AI Music Deal with Universal Music Group and Upbeat Guidance Superyacht Season Kicks Off in Cannes Luxury Spending and Carbon Debt in Focus US Jobless Claims Remain Near Historic Lows in Latest Week US Manufacturers Slow to Adopt AI and Automation Amid Implementation Hurdles FIGS Q1 2026 Earnings Strong EPS Surprise Highlights Margin Improvement ARMK Q1 2026 Earnings EPS Slightly Misses Estimates Amid Mixed Market Reaction STRK Q1 2026 Earnings Preferred Stock Reports Deep EPS Shortfall as Revenue Remains Undisclosed FTNT Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Unavailable NerdWallet Q1 2026 Earnings EPS Beats Estimates by 108 Amid Strong Performance Intelligent Bio Solutions Inc INBS Q1 2025 Earnings Wider Loss Than Expected Weighs on Shares eToro Group ETOR Gains Ground Testing Resistance After 313 Rally Wen Acquisition Corp WENN Holds Steady at 1027 as Market Awaits Catalyst PriceSmart Holds Steady as PSMT Trades Near Support Amid Quiet Session eHealth Inc EHTH Nears Support as Selling Pressure Continues GSK Shares Edge Higher Amid Steady Trading ECB HellBent on Rate Hikes Could Be a Big Mistake Amid Stagflation Risks Berenberg Chief Economist Warns Sprinklr CXM Q1 2026 Earnings EPS Surges Past Estimates by 34 Despite Lack of Revenue Disclosure American Bitcoin Corp ABTC Slips Marginally as Price Hovers Near Support Valero Energy VLO Q1 2026 Earnings Strong EPS Beat Signals Resilience in Refining Margins ALIT Q1 2026 Earnings EPS Surprises 34 Above Estimates Stock Edges Higher D Q1 2026 Earnings EPS Beats Estimates as Regulated Earnings Support Growth NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline SDRL Q1 2026 Earnings NarrowerthanExpected Loss Boosts Surprise but Shares Slip SIM Q1 2023 Earnings EPS Falls Short of Estimates Missing by Over 57 DSGN Q1 2026 Earnings EPS Beats Estimates as Development Stage Biotech Advances Pipeline